Cargando…
New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
Targeting DNA repair proteins with small-molecule inhibitors became a proven anti-cancer strategy. Previously, we identified an inhibitor of a major protein of homologous recombination (HR) RAD51, named B02. B02 inhibited HR in human cells and sensitized them to chemotherapeutic drugs in vitro and i...
Autores principales: | Shkundina, Irina S., Gall, Alexander A., Dick, Alexej, Cocklin, Simon, Mazin, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235719/ https://www.ncbi.nlm.nih.gov/pubmed/34208492 http://dx.doi.org/10.3390/genes12060920 |
Ejemplares similares
-
Homologous recombination, cancer and the ‘RAD51 paradox’
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021) -
Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination
por: Taylor, Martin R.G., et al.
Publicado: (2015) -
Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
por: Gu, Peng, et al.
Publicado: (2022) -
Repression of mutagenesis by Rad51D-mediated homologous recombination
por: Hinz, John M., et al.
Publicado: (2006) -
Reappearance from Obscurity: Mammalian Rad52 in Homologous Recombination
por: Hanamshet, Kritika, et al.
Publicado: (2016)